← Leaderboards
Rami A Al-Horani
Xavier University Of Louisiana
$874,592
Attributed
$874,592
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $150K · FY2019–25$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$874,592 · 2
By mechanism
R16$448,592 · 1
SC3$426,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Xavier University Of Louisiana
Same institution · by research overlap
- Syreeta L Tilghman$2,263,079
- Tien L Huang$1,093,958
- Hector Ramos Biliran$1,585,088
- Guangdi Wang$13,394,490
- Tarun K Mandal$1,220,603
Others in their field
Other Emerging Leaders on “Hemostatic Function”
- Angelo D'alessandro · University Of Colorado Denver$4,428,843
- Timothy Nichols · Univ Of North Carolina Chapel Hill$4,267,569
- Sol Schulman · Beth Israel Deaconess Medical Center$3,685,783
- Laura Brienne Harrington · Kaiser Foundation Research Institute$3,403,626
- Pavan Bendapudi · Beth Israel Deaconess Medical Center$3,093,888
- Joseph E Aslan · Oregon Health & Science University$2,927,526
Research focus
Hemostatic FunctionMolecular ModelingExperimental StudyHemorrhageInterdisciplinary ApproachLibrariesDesignExhibitsAlkanesulfonatesFutureInnovationAreaAnimal ModelLeadAffectClinically RelevantAnticoagulantsEvaluationBiochemicalBiologicalCessation Of LifeFactor XaCoagulation ProcessMorbidity - Disease Rate
Grant awards (7)
Inhibitors of Human Factor XIIIa as New Anticoagulants$150,000
R16 · FY2025 · GM · contact PI
Inhibitors of Human Factor XIIIa as New Anticoagulants$149,592
R16 · FY2024 · GM · contact PI
Inhibitors of Human Factor XIIIa as New Anticoagulants$149,000
R16 · FY2023 · GM · contact PI
Inhibitors of the Intrinsic Pathway of Coagulation as New Anticoagulants$106,500
SC3 · FY2022 · GM · contact PI
Inhibitors of the Intrinsic Pathway of Coagulation as New Anticoagulants$106,500
SC3 · FY2021 · GM · contact PI
Inhibitors of the Intrinsic Pathway of Coagulation as New Anticoagulants$106,500
SC3 · FY2020 · GM · contact PI
Inhibitors of the Intrinsic Pathway of Coagulation as New Anticoagulants$106,500
SC3 · FY2019 · GM · contact PI